News
age related macular degeneration
Phase 2b clinical trials set for potential AMD treatment
More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...
age related macular degeneration
AMD patients with visual disability at higher risk of cardiovascular disease
Researchers at Sungkyunkwan University School of Medicine in Korea conducted a nationwide cohort study involving nearly 4 million adults.
age-related macular degeneration
FDA approves first drug to treat geographic atrophy
Geographic atrophy typically affects people over the age of 50 and is one of the main causes of vision loss in the United States.
age-related macular degeneration
Potential cause of AMD identified
Researchers discovered a rare genetic variant that generates malformed proteins that change the stability of the membrane attack complex (MAC).
age related macular degeneration
How the eye gives us a glimpse into human aging
The eye has been said to be the window to the soul and it may also offer us a glimpse into human aging.
age-related macular degeneration
Higher serum vitamin D levels play a role in stages of AMD
Researchers recently examined data from the National Health and Nutrition Examination Survey (NHANES) to determine the link between serum vitamin D levels and the odds of developing different subt...
age-related macular degeneration
Macular degeneration linked to obesity
Researchers were examining why some people with a genetic predisposition develop age-related macular degeneration (AMD) while others with the genetic predisposition do not.
age-related macular degeneration
Lab-grown retinal cells indicate possibility of clinical trials
Researchers hope that these cells are ready to be studied in human clinical trials
age related macular degeneration
Genetic link between COVID risk and macular-degeneration
Researchers analyzed genetic data from more than 16,000 people with AMD, more than 50,000 people with COVID along with control groups.